NEW YORK, July 12, 2018 /PRNewswire/ -- This report analyzes the worldwide markets for Stem Cell Technologies in US$ Million.
Read the full report: https://www.reportlinker.com/p02043289
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 66 companies including many key and niche players such as:
- Athersys, Inc.
- Apceth GmbH & Co.KG
- AVIVA BioSciences Corporation
- BioE, Inc.
- Bone Therapeutics SA
Read the full report: https://www.reportlinker.com/p02043289
STEM CELLS MCP-6142 A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
Select Approved Stem Cell Products
Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
Trends Related to Stem Cell Clinical Trials
Table 1: Clinical Tests by Type: Allogenic Vs. Autologous (In%) (includes corresponding Graph/Chart)
Table 2: Stem Cells Clinical Trials by Country: 2008-2014 (includes corresponding Graph/Chart)
Select Stem Cell Pipeline Analysis
Current & Future Analysis
Stem Cell Research Funding Policies across the World
Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
Dental Mesenchymal Stem Cells - Emergence of a Niche Market
For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern
2. STEM CELL RESEARCH INNOVATIONS
Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
Embryonic Stem Cell Gene Nanog Found to Reverse Aging
Canadian and Dutch Scientists Finds the €œGenetic Switch€ to Increase Stem Cell Volume from Cord Blood
The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
Adverse Reactions of Stem Cell-Face Lift Therapy
Stem Cell-Breast Enhancement
Other Innovations Using Stem Cells
New Stem Cell Software & Products
3. PRODUCT OVERVIEW
4. PRODUCT LAUNCHES
Minerva Biotechnologies Launches AlphaSTEM„¢, a Naïve Stem Cell Culture System
Takara Bio Launches Human iPSC-Derived Beta Cells for Drug Screening and Diabetes Research
RenovaCare Develops New Stem Cell Device for Burn Injuries
Mesoblast Launches the Worlds First Off-The-Shelf Stem Cell Treatment
Mesoblast Licensee launches first stem cell product in Japan
Stempeutics Research Receives Approval for India's First Stem Cell Based Drug
5. CLINICAL TRIALS
Nature Cell Commences Phase I and II Clinical Trials of €˜ ASTROSTEM in the US for Treating Alzheimer
Tisch MS Research Center Commences Phase II Stem Cell Clinical Trial for MS
Canadian Clinical Trial to Test Neural Stem Cells in Patients with Spinal Cord Injuries
Neuralstems ALS Stem Cell Therapy Exhibits Safety and Efficacy in Early Clinical Trials
The University of Michigan Commences Large Scale Clinical Trials for ALS Therapy
Bionomics Receives FDA Approval for Phase I Clinical Trial in Cancer Patients
AHSCT Shows Reduced Brain Lesions in Phase 2 Clinical Trial
Neuralstems Neural Stem Cell Treatment Meets Primary Safety Endpoints in Phase 2 Trials
6. RECENT INDUSTRY ACTIVITY
GE Health Acquires Biosafe
Human Longevity Acquires Lifebank
AbbVie to Acquire Stemcentrx and Its Lead Asset Rova-T
Thorn Medical Acquires Okyanos Holding Company
Bio-Techne Corporation Acquires Zephyrus Biosciences
Astellas Pharma to Complete Acquisition of Ocata Therapeutics
Bayer Launches Stem Cell Therapy Company BlueRock Therapeutics
apceth Signs License Option Agreement with Cynata Therapeutics Ltd
StemBioSys Announces European Distribution Agreement with Cellaviva AB of Sweden
Fujifilm Holdings Acquires Cellular Dynamics International
American CryoStem Corporation Acquires Biolife Cell Bank
NeoStem Announces Plans to Change Name to Caladrius Biosciences Reflecting Transformation into Immunotherapy Company
ESI BIO Announces Alliance Agreement with Pivotal Scientific Ltd for Distribution of Stem Cell Products
TiGenix and Lonza Signs Agreement for the Manufacture of Stem Cell-based Treatment
AlloSource Receives Patent for AlloStem® Cellular Bone Allograft
7. FOCUS ON SELECT GLOBAL PLAYERS
Athersys, Inc. (USA)
Apceth GmbH & Co.KG (Germany)
AVIVA BioSciences Corporation (USA)
BioE, Inc. (USA)
Bone Therapeutics SA (Belgium)
Cesca Therapeutics, Inc. (USA)
Cryo-Cell International, Inc. (USA)
Cytori Therapeutics, Inc. (USA)
ESI BIO, a Division of BioTime Inc. (USA)
Gamida Cell Ltd. (Israel)
Holostem Terapie Avanzate (Italy)
International Stem Cell Corporation (USA)
Kangstem Biotech., Ltd. (Korea)
Lonza Group Ltd (Switzerland)
Mesoblast Ltd. (Australia)
Neuralstem, Inc. (USA)
Nuvasive, Inc. (USA)
Osiris Therapeutics, Inc. (USA)
OncoMed Pharmaceuticals, Inc (USA)
PROMETHERA Biosciences S.A.N.V (Belgium)
Reliance Life Sciences (India)
ReNeuron Group Plc. (UK)
STEMCELL Technologies, Inc. (Canada)
Stemedica Cell Technologies, Inc (USA)
Stempeutics Research Pvt. Ltd. (India)
Takara Bio USA Inc (USA)
TiGenix NV (Belgium)
U.S Stem Cell, Inc. (USA)
ViaCord, LLC (USA)
8. GLOBAL MARKET PERSPECTIVE
Table 3: World Recent Past, Current and Future Analysis for Stem Cell Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 4: World 8-Year Perspective for Stem Cell Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2017 and 2024 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
A.Market Analysis
Hemacord - The Only FDA-Approved Cord Blood-Derived Hematopoietic Progenitor Cells
FDA to Implement Strict Regulations on Unapproved Stem Cell Treatment
Consumer Watchdog against Embryonic- Stem Cell Patents
Clinical Trials
Strategic Corporate Developments
Product Launches
Select Key Players
B.Market Analytics
Table 5: The US Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
2. CANADA
A.Market Analysis
Stem Cell Initiatives
Clinical Trials
Select Key Player
B.Market Analytics
Table 6: Canadian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
3. JAPAN
A.Market Analysis
Multinational Companies Leverage Japans Relaxed Regulatory Regime for Furthering Stem Cell Research
Strategic Corporate Development
B.Market Analytics
Table 7: Japanese Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
4. EUROPE
A.Market Analysis
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 8: European Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - France, Germany, Italy, UK, Spain, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 9: European 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of European Markets for Years 2017 & 2024 (includes corresponding Graph/Chart)
4a. FRANCE
Market Analysis
Table 10: French Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
4b. GERMANY
Market Analysis
Table 11: German Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 12: Italian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Stem Cell Storage Venture by NHS Trust Aims to Improve Public Donation
UK Scientists Use Adult-Stem Cells for Treating Multiple Sclerosis
B.Market Analytics
Table 13: The UK Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analysis
Table 14: Spanish Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
4f. REST OF EUROPE
A.Market Analysis
Stem Cell Research Gains Momentum in Russia
B.Market Analytics
Table 15: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
A.Market Analysis
India & China: Potential-Laden Populous Markets for Stem Cell Research
Table 16: Ten Largest Populated Countries Worldwide (July 2015): Total Population (in Millions) by Age Group 0-14 Years, 15-59 Years, 60+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Mexico (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Development
Select Key Players
B.Market Analytics
Table 17: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 18: Asia-Pacific 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2017 & 2024 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Chinese Stem Cell Market Set to Register Robust Growth
Chinese Market for Stem Cell Research: Lack of Technological Innovation Restrains Governmental Initiatives
B.Market Analytics
Table 19: Chinese Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
5b. REST OF ASIA-PACIFIC
A.Market Analysis
Steady Strides in Indias Stem Cells Market
Regulatory Guidelines Promote Ethical Harvesting of Stem Cells
Indian Researchers use Hair Follicle and Skin Stem Cells for Burn and Vitiligo Patients
Stem Cell Research€"Imperative for Australia
Korean Scientists Develop Technique to Use Stem Cells for Treating Macular Degeneration
Select Stem Cell Products Approved in the Korean Market
B.Market Analytics
Table 20: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
6. LATIN AMERICA
Market Analysis
Table 21: Latin American Recent Past, Current & Future Analysis for Stem Cell Technologies by Geographic Region/Country - Brazil, and Rest of Latin America Markets Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 22: Latin American 6-Year Perspective for Stem Cell Technologies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin America Markets for Years 2017 & 2024 (includes corresponding Graph/Chart)
6a. BRAZIL
Market Analysis
Table 23: Brazilian Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
6b. REST OF LATIN AMERICA
Market Analysis
Table 24: Rest of Latin America Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
7. REST OF WORLD
A.Market Analysis
Select Key Player
B.Market Analytics
Table 25: Rest of World Recent Past, Current & Future Analysis for Stem Cell Technologies Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 66 (including Divisions/Subsidiaries - 69) The United States (39) Canada (1) Japan (1) Europe (13) - Germany (2) - The United Kingdom (5) - Italy (1) - Rest of Europe (5) Asia-Pacific (Excluding Japan) (12) Middle East (1) Latin America (1)
Read the full report: https://www.reportlinker.com/p02043289
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article